Biotech Investment News: Roche’s Major Deals Over the Past Decade (2015–2025)
Strategic Review: Expanding from Monoclonal Antibodies into Diagnostics, RNA, and Cell Therapy Roche has long been a global leader in monoclonal antibody-based cancer therapies. Roche has long been a global leader in monoclonal antibody-...
